Anemia Diagnosis & Treatment: Clinical Algorithm Guide
Anemia evaluation follows a structured morphologic and etiologic approach. This guide outlines the diagnostic pathway by RBC indices.
Initial Classification by MCV
Microcytic (MCV <80 fL): Hypochromic
- Iron Deficiency Anemia (IDA): Most common. Confirm: Low ferritin (<30 ng/mL), high TIBC, low transferrin saturation (<16%). Trial of oral iron → reticulocytosis in 7-10 days, Hb rise in 2-3 weeks confirms.
- If iron replete or non-responsive:
- Thalassemia trait: Normal/high ferritin, high RBC count, Mentzer index (MCV/RBC) <13. Confirm: Hb electrophoresis, genetic testing
- Anemia of chronic disease (ACD): Normal/high ferritin, low TIBC, low serum iron. Often normocytic but can be microcytic.
- Sideroblastic anemia: Ring sideroblasts on marrow; genetic or acquired (alcohol, drugs, lead)
- Bone marrow biopsy: If diagnosis unclear after above
Macrocytic (MCV >100 fL)
- Megaloblastic: B12 or folate deficiency
- Measure serum B12, folate, methylmalonic acid (MMA), homocysteine
- B12 deficiency: ↑MMA, ↑homocysteine; Folate deficiency: ↑homocysteine only
- If levels borderline/normal but high suspicion → bone marrow
- Non-megaloblastic:
- Alcohol, liver disease, hypothyroidism, drugs (hydroxyurea, metformin), MDS
- Reticulocytosis (hemolysis, recovery)
Normocytic (MCV 80-100 fL)
- Anemia of chronic disease/inflammation (most common in hospitalized)
- Renal failure (EPO deficiency)
- Endocrine (hypothyroid, adrenal insufficiency)
- Early iron deficiency or mixed deficiencies
- Bone marrow failure (aplastic, MDS, infiltration)
- Hemolysis (check reticulocyte count, LDH, haptoglobin, bilirubin, DAT)
- Acute blood loss
Hemoglobinopathy/Thalassemia Workup
- Hb electrophoresis/HPLC: Identifies HbS, HbC, HbE, HbF, HbA2 elevation (β-thal trait)
- Alpha-thalassemia: Genetic testing (deletions); not on electrophoresis
- DNA sequencing for rare mutations
Bone Marrow Indications
- Pancytopenia or bicytopenia
- Unexplained macrocytosis
- Suspected MDS, leukemia, myelofibrosis, infiltration
- Persistent anemia despite adequate treatment trial
Treatment Principles
- Treat cause: Iron/B12/folate replacement, EPO for CKD, immunosuppression for AIHA, etc.
- Transfusion threshold: Hb <7 g/dL (most); <8 g/dL (cardiovascular disease); symptomatic regardless of Hb
- Monitor: Reticulocyte response, Hb trend, iron studies, B12/folate if replaced
Always correlate with clinical picture: bleeding, hemolysis, nutrition, medications, comorbidities.
Blood Disorders - Related Articles
- Pentoxifylline: Understanding Risks & Side Effects
- Neutrophils and Cancer Treatment: Understanding the Connection
- Jehovah's Witnesses and Blood Transfusions: Alternatives and Beliefs
- Debunking the Myth: Did Mary I Bathe in Blood?
- Thrombophilia: Blood Clotting Disorders—Types, Risks, and Management
- Hyperkalemia Diet: Foods to Avoid and Manage Potassium Levels
- Anaplastic Thyroid Cancer: Understanding Prognosis and Treatment
